Misrouted cell surface receptors as a novel disease aetiology and potential therapeutic target: the case of hypogonadotropic hypogonadism due to gonadotropin-releasing hormone resistance

Author： Ulloa-Aguirre Alfredo   Janovick Jo Ann   Leaños-Miranda Alfredo   Conn P Michael  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.2, 2003-04, pp. : 175-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Estrogen Myth: Potential Use of Gonadotropin-Releasing Hormone Agonists for the Treatment of Alzheimer's Disease

By Casadesus Gemma  

Drugs in R&D, Vol. 7, Iss. 3, 2006-01 ,pp. : 187-193

Adis International

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonists

By Herbst K.L.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 660-666

Elsevier

Access to resources Recommend Favorite

Emerging gonadotropin-releasing hormone agonists

By Beyer Daniel Alexander   Amari Feriel   Thill Marc   Schultze-Mosgau Askan   Al-Hasani Safaa   Diedrich Klaus   Griesinger Georg  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 323-340

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonists reviewed

By  

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Effectiveness of Gonadotropin Administration for Spermatogenesis Induction in Hypogonadotropic Hypogonadism: A Possible Role of Androgen Receptor CAG Repeat Polymorphism and Therapeutic Measures

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 3, 2012-09 ,pp. : 236-242

Bentham Science Publishers

Access to resources Recommend Favorite